Atlas Trials

Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes

Clinical trial NCT04529616 · COMPLETED

Trial details

NCT number
NCT04529616
Sponsor
RxSight, Inc.
Status
COMPLETED
Study type
INTERVENTIONAL
AphakiaCataract
Start date
2020-05-22
Primary completion
2022-10-01
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.